ArticleCancer gene therapy2025

SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1.

Octavio A Trejo-Villegas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.